Literature DB >> 27365075

Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.

Yang Cao1, Hatasu Kobayashi1, Takaaki Morimoto1,2, Risako Kabata1, Kouji H Harada1, Akio Koizumi3.   

Abstract

OBJECTIVES: RNF213 p.R4810K is a founder polymorphism that confers genetic susceptibility to moyamoya disease in East Asia. Only a few studies have investigated the symptoms and disease histories of RNF213 p.R4810K carriers in Japan. This study investigated the frequency of RNF213 p.R4810K in the general Japanese population and the health characteristics of the carriers.
METHODS: Through a health-promotion campaign in the city of Uji, Japan, 519 subjects (120 males and 399 females) of the general Japanese population were genotyped for RNF213 p.R4810K and interviewed to determine health characteristics.
RESULTS: Nine RNF213 p.R4810K heterozygous carriers (GA genotype) and no RNF213 p.R4810K homozygous carriers (AA genotype) were found among the 519 individuals. The estimates of the genotypes and allele frequencies for RNF213 p.R4810K were 1.73 and 0.87 %, respectively. There were no obvious differences in age, gender ratio, body mass index, hypertension, dyslipidemia, diabetes, kidney disease, liver disease, heart disease, or drinking or smoking habits between carriers and non-carriers. Interestingly, one patient with moyamoya disease was found among the nine RNF213 p.R4810K carriers.
CONCLUSIONS: This study showed the genotypes and allele frequencies of RNF213 p.R4810K in the general Japanese population to be similar to results of previous reports.

Entities:  

Keywords:  General population; Japan; Moyamoya disease; RNF213; p.R4810K

Mesh:

Substances:

Year:  2016        PMID: 27365075      PMCID: PMC5305994          DOI: 10.1007/s12199-016-0549-8

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  13 in total

1.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.

Authors:  Fumiaki Kamada; Yoko Aoki; Ayumi Narisawa; Yu Abe; Shoko Komatsuzaki; Atsuo Kikuchi; Junko Kanno; Tetsuya Niihori; Masao Ono; Naoto Ishii; Yuji Owada; Miki Fujimura; Yoichi Mashimo; Yoichi Suzuki; Akira Hata; Shigeru Tsuchiya; Teiji Tominaga; Yoichi Matsubara; Shigeo Kure
Journal:  J Hum Genet       Date:  2010-11-04       Impact factor: 3.172

2.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

3.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

4.  Epidemiological features of moyamoya disease in Japan.

Authors:  Haruhiko Hoshino; Yoshikane Izawa; Norihiro Suzuki
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

5.  Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.

Authors:  Wanyang Liu; Toshiaki Hitomi; Hatasu Kobayashi; Kouji H Harada; Akio Koizumi
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

Review 6.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

7.  Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study.

Authors:  Il Min Ahn; Dong-Hyuk Park; Hoo Jae Hann; Kyoung Hoon Kim; Hyun Jung Kim; Hyeong Sik Ahn
Journal:  Stroke       Date:  2014-03-04       Impact factor: 7.914

8.  Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.

Authors:  Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Shinichi Yagi; Hideaki Ono; Akitake Mukasa; Hirofumi Nakatomi; Tsuneo Shimizu; Nobuhito Saito
Journal:  Stroke       Date:  2013-08-22       Impact factor: 7.914

9.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

10.  Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.

Authors:  Zhiyuan Wu; Hanqiang Jiang; Lei Zhang; Xiao Xu; Xinju Zhang; Zhihua Kang; Donglei Song; Jin Zhang; Ming Guan; Yuxiang Gu
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more
  8 in total

1.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

2.  RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.

Authors:  Liyin Zhang; Sherif Rashad; Yuan Zhou; Kuniyasu Niizuma; Teiji Tominaga
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-25       Impact factor: 6.960

3.  Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.

Authors:  Tong Zhang; Congrong Guo; Xin Liao; Jian Xia; XiaoXiao Wang; Jing Deng; Junxia Yan
Journal:  Environ Health Prev Med       Date:  2017-04-24       Impact factor: 3.674

4.  Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.

Authors:  Takaaki Morimoto; Yohei Mineharu; Koh Ono; Masahiro Nakatochi; Sahoko Ichihara; Risako Kabata; Yasushi Takagi; Yang Cao; Lanying Zhao; Hatasu Kobayashi; Kouji H Harada; Katsunobu Takenaka; Takeshi Funaki; Mitsuhiro Yokota; Tatsuaki Matsubara; Ken Yamamoto; Hideo Izawa; Takeshi Kimura; Susumu Miyamoto; Akio Koizumi
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

5.  Differences in the Genotype Frequency of the RNF213 Variant in Patients with Familial Moyamoya Disease in Kyushu, Japan.

Authors:  Yuichiro Takamatsu; Ken Higashimoto; Toshiyuki Maeda; Masatou Kawashima; Muneaki Matsuo; Tatsuya Abe; Toshio Matsushima; Hidenobu Soejima
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-09-21       Impact factor: 1.742

Review 6.  Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

Authors:  Yuting Luo; Zhixin Cao; Shaoqing Wu; Xunsha Sun
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

7.  Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1.

Authors:  Masanori Iwanishi; Choka Azuma; Yuji Tezuka; Yukako Yamamoto; Jun Ito-Kobayashi; Miki Washiyama; Toru Kusakabe; Shingo Kikugawa
Journal:  Intern Med       Date:  2020-10-15       Impact factor: 1.271

8.  RNF213 p.R4810K (c.14429G > A) Variant Determines Anatomical Variations of the Circle of Willis in Cerebrovascular Disease.

Authors:  Futoshi Eto; Takeshi Yoshimoto; Shuhei Okazaki; Kunihiro Nishimura; Shiori Ogura; Eriko Yamaguchi; Kazuki Fukuma; Satoshi Saito; Kazuo Washida; Masatoshi Koga; Kazunori Toyoda; Takaaki Morimoto; Hirofumi Maruyama; Akio Koizumi; Masafumi Ihara
Journal:  Front Aging Neurosci       Date:  2021-07-15       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.